Administration of 40 mg of tenofovir alafenamide for 14 days resulted in lower tenofovir Cmax ( 13 versus 207 ng/mL ) and lower systemic exposures ( AUC0-t , 383 versus 1810 ngh/mL ) compared with subjects who received tenofovir disoproxil fumarate .